On August 11, 2021 Cytocom, Inc. (NASDAQ: CBLI), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, reported that the company will participate at the Empowering the Kingdom through Business Conference hosted by the Liberty University School of Business on August 10-12, 2021 (Press release, Cytocom, AUG 11, 2021, https://www.cytocom.com/2021/08/11/cytocom-inc-announces-participation-at-liberty-universitys-empowering-the-kingdom-through-business-conference/?utm_source=rss&utm_medium=rss&utm_campaign=cytocom-inc-announces-participation-at-liberty-universitys-empowering-the-kingdom-through-business-conference [SID1234586287]). Cytocom President and CEO, Mike K. Handley, will participate live as a featured panelist in the Healthcare Breakout session moderated by Dean Joseph Johnson on August 11, 2021.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!